TA
ARIA

Teachers Advisors’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Teachers Advisors’s Portfolio ARIA Stock Details ARIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-348,713
Closed -$4.34M – 3110
2016
Q4 		$4.34M Buy
348,713
+7,132
+2% +$85.9K 0.01% 1360
2016
Q3 		$4.68M Buy
341,581
+3,261
+1% +$32.7K 0.01% 1234
2016
Q2 		$2.5M Buy
338,320
+32,919
+11% +$247K ﹤0.01% 1520
2016
Q1 		$1.95M Hold
305,401
– – ﹤0.01% 1589
2015
Q4 		$1.91M Buy
305,401
+4,731
+2% +$31K ﹤0.01% 1624
2015
Q3 		$1.76M Buy
300,670
+56,633
+23% +$436K ﹤0.01% 1647
2015
Q2 		$2.02M Buy
244,037
+6,454
+3% +$57.1K ﹤0.01% 1682
2015
Q1 		$1.96M Buy
237,583
+9,062
+4% +$67K ﹤0.01% 1671
2014
Q4 		$1.57M Hold
228,521
– – ﹤0.01% 1779
2014
Q3 		$1.23M Sell
228,521
-4,871
-2% -$28.4K ﹤0.01% 1889
2014
Q2 		$1.49M Buy
233,392
+117,817
+102% +$810K ﹤0.01% 1825
2014
Q1 		$932K Buy
115,575
+81,767
+242% +$637K ﹤0.01% 2066
2013
Q4 		$231K Sell
33,808
-250,645
-88% -$1.35M ﹤0.01% 2795
2013
Q3 		$5.23M Buy
284,453
+9,973
+4% +$194K 0.01% 1015
2013
Q2 		$4.8M Buy
+274,480
New +$4.87M 0.01% 1012

Other funds holding ARIA

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

Teachers Advisors's ARIA Position: Q1 2017 in Review

Teachers Advisors sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2017, closing a stake of 348,713 shares — an estimated $4.34M sold.

Teachers Advisors first reported a position in ARIA in Q2 2013 and held it in 15 quarters. The position peaked at $5.23M in Q3 2013. 1 fund tracked by Wall St. Rank holds ARIA as of Q1 2017.

  • Teachers Advisors reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
  • Teachers Advisors sold 348,713 Ariad Pharmaceuticals Inc shares in Q1 2017, an estimated $4.34M.
  • Teachers Advisors first reported a position in Ariad Pharmaceuticals Inc in Q2 2013 and held it in 15 quarters.
  • Teachers Advisors's Ariad Pharmaceuticals Inc position peaked at $5.23M in Q3 2013.
  • 1 fund tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2017.

Based on Teachers Advisors's 13F filing for Q1 2017, filed 11 May 2017.